DJIA 18,080.14 0.00 0.00%
NASDAQ 5,092.09 0.00 0.00%
S&P 500 2,117.69 0.00 0.00%
market minute promo

Celgene (NASDAQ: CELG)

118.71 0.00 (0.00%)

REAL-TIME: Last trade at

Extended Hours: $118.71 $0.00 (0.00%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

CELG $118.71 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.00
Previous Close $118.71
Daily Range $0.00 - $0.00
52-Week Range $69.88 - $129.06
Market Cap $95.0B
P/E Ratio 49.67
Dividend (Yield) $0.00 (0.0%)
Volume 0
Average Daily Volume 5,914,440
Current FY EPS $4.42




Drug Makers

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website:

News & Commentary

3 Mega-Cap Stocks That Shouldn't Pay a Dividend

Mega-cap stocks are generally profitable and overflowing with free cash, leading many to pay handsome dividends. However, these three mega-cap stocks aren't currently paying a dividend -- and if their management teams are smart, they'll keep it that way for many years to come!

Short Sellers Become More Wary of Big Biotech

Benzinga's Weekend M&A Chatter

Trusty Horses; Tools, Pizza and Shoes: Jim Cramer's Best Blogs

Celgene Signals Bigger Immuno-Oncology Push Into Blood Cancers

AstraZeneca Inks Multiple Deals, Immuno-Oncology in Focus - Analyst Blog

Health Care Sector Update for 04/24/2015: CELG, EHTH, AERI

Why A Bristol-Myers Squibb Bid On Celgene Is Plausible

Jim Cramer Loves Regeneron, Sees Shares Headed to $500

Watch Out: Barbarians At The Gate For Celgene (CELG)

See More CELG News...

CELG's Top Competitors

CELG $118.71 (0.00%)
Current stock: CELG
AMGN $167.91 (0.00%)
Current stock: AMGN
GILD $103.70 (0.00%)
Current stock: GILD
$0.00 (0.00%)
Current stock: